Solaro C, Trabucco E, Signori A, Cella M, Messmer Uccelli M, Brichetto G, Cavalla P, Gironi M, Patti F, Prosperini L
Neurology Unit, Head and Neck Department, ASL 3 "Genovese", 16154 Genova, Italy.
Neurology Unit, Head and Neck Department, ASL 3 "Genovese", 16154 Genova, Italy ; Department of Experimental Medicine, Section of Diagnostic Radiology, University of Genoa, 16126 Genova, Italy.
Mult Scler Int. 2015;2015:540828. doi: 10.1155/2015/540828. Epub 2015 Mar 26.
Objective. Gait impairment is commonly in people with multiple sclerosis (MS). The 12-item MS walking scale (MSWS-12) assesses patients' measurement of walking quality. The aim of this study was to cross-culturally adapt and validate the MSWS-12 for the Italian population with MS. Methods. Six MS out-patient clinics across Italy enrolled subjects between June 2013 and December 2013. Construct validity of MSWS-12 was determined by examining correlations with the Italian version of the EDSS, the timed 25-foot walk (T25FW), and the Fatigue Severity Scale (FSS). Results. 321 MS subjects were enrolled. Mean age was 47.55 years and mean disease duration was 13.8 years. Mean EDSS score was 4.46. 185 subjects had a relapsing-remitting course, 92 were secondary progressive, 43 were primary progressive, and 1 had a clinically isolated syndrome. The mean total score of the MSWS-12 was 49.6 (SD: 31) with values ranging between 0 and 100. Correlations between the MSWS-12 with age, disease duration, and disease course were found but not with gender. Values of the MSWS-12/IT were significantly related to EDSS (0.71), to the T25FW (0.65), and to the FSS (0.51). Conclusion. MSWS-12/IT has been adapted and validated, it is a reliable and reproducible scale for Italian patients with MS.
目的。步态障碍在多发性硬化症(MS)患者中很常见。12项MS步行量表(MSWS - 12)用于评估患者对步行质量的测量。本研究的目的是对MSWS - 12进行跨文化改编并验证其在意大利MS患者群体中的有效性。方法。2013年6月至2013年12月期间,意大利的6家MS门诊招募了受试者。通过检查与意大利版扩展残疾状态量表(EDSS)、25英尺定时步行(T25FW)和疲劳严重程度量表(FSS)的相关性来确定MSWS - 12的结构效度。结果。共招募了321名MS受试者。平均年龄为47.55岁,平均病程为13.8年。平均EDSS评分为4.46。185名受试者为复发缓解型病程,92名为继发进展型,43名为原发进展型,1名患有临床孤立综合征。MSWS - 12的平均总分是49.6(标准差:31),取值范围在0到100之间。发现MSWS - 12与年龄、病程和疾病类型之间存在相关性,但与性别无关。MSWS - 12/IT的值与EDSS(0.71)、T25FW(0.65)和FSS(0.51)显著相关。结论。MSWS - 12/IT已完成改编和验证,它是用于意大利MS患者的可靠且可重复的量表。